StonvexLoading…
StonvexStonvexStonvexCore line items from NPKI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $75.07M | $277.04M | $201.85M | $133.01M |
Operating Income | $14.42M | $46.78M | $34.21M | $25.16M |
Net Income | $10.46M | $38.94M | $24.34M | $18.68M |
EPS (Diluted) | $0.12 | $0.45 | $0.28 | $0.22 |
Total Assets | $437.89M | $441.76M | $404.46M | $393.68M |
Total Liabilities | $78.11M | $90.60M | $70.54M | $64.85M |
Cash & Equivalents | $6.54M | $5.14M | $35.64M | $26.01M |
Free Cash Flow OCF − CapEx | $4.43M | $26.32M | $20.57M | $8.56M |
Shares Outstanding | 85.85M | 90.13M | 85.82M | 86.20M |